Occurrence and Molecular Study of Hypermucoviscous/Hypervirulence Trait in Gut Commensal from Healthy Subjects
Overview
Authors
Affiliations
Hypervirulent (hvKp) is emerging worldwide. Hypermucoviscousity is the characteristic trait that distinguishes it from classic (cKp), which enables Kp to cause severe invasive infections. This research aimed to investigate the hypermucoviscous Kp (hmvKp) phenotype among gut commensal Kp isolated from healthy individuals and attempted to characterize the genes encoding virulence factors that may regulate the hypermucoviscosity trait. Using the string test, 50 identified Kp isolates from healthy individuals' stool samples were examined for hypermucoviscosity and investigated by transmission electron microscopy (TEM). Antimicrobial susceptibility profiles of Kp isolates were determined using the Kirby Bauer disc method. Kp isolates were tested for genes encoding different virulence factors by PCR. Biofilm formation was assayed by the microtiter plate method. All Kp isolates were multidrug-resistant (MDR). Phenotypically, 42% of isolates were hmvKp. PCR-based genotypic testing revealed the hmvKp isolates belonged to capsular serotype K2. All study Kp isolates harbored more than one virulence gene. The genes and were not detected, while the gene was present in all isolates. The siderophores encoding genes and were most prevalent in hmvKp isolates (90.5%) and non-hmvKp (96.6%), respectively. hmvKp isolates harbored the genes and with rates of 90.5% and 85.7%, respectively. The outcomes of this research highlight the potential health risk of commensal Kp to cause severe invasive diseases, owing to being hmvKp and MDR, and harboring multiple virulence genes. The absence of essential genes related to hypermucoviscosity such as and in hmvKp phenotypes suggests the multifactorial complexity of the hypermucoviscosity or hypervirulence traits. Thus, further studies are warranted to verify the hypermucoviscosity-related virulence factors among pathogenic and commensal Kp in different colonization niches.
Qala Nou M, Amirian Z, Dehghani F, Vejdan A, Rooin R, Dehghanmehr S BMC Pharmacol Toxicol. 2025; 26(1):25.
PMID: 39885589 PMC: 11783860. DOI: 10.1186/s40360-025-00857-8.
Azra , Khan T, Ul Haq I, Hinthong W, Campino S, Gohar A Pathogens. 2025; 14(1).
PMID: 39861040 PMC: 11768992. DOI: 10.3390/pathogens14010079.
Mohammed R, Nader S, Hamza D, Sabry M Ann Clin Microbiol Antimicrob. 2024; 23(1):53.
PMID: 38886796 PMC: 11184735. DOI: 10.1186/s12941-024-00711-5.
Morphological, biological, and genomic characterization of Klebsiella pneumoniae phage vB_Kpn_ZC2.
Fayez M, Hakim T, Zaki B, Makky S, Abdelmoteleb M, Essam K Virol J. 2023; 20(1):86.
PMID: 37138257 PMC: 10158348. DOI: 10.1186/s12985-023-02034-x.